Construction work on Yixing Ophthalmic Drug ADC Production Facility located in Jiangsu, China commenced in Q3 2024, after the project was announced in Q1 2023. According to GlobalData, who tracks and profiles more than 220,000 major construction projects from announcement to completion, the project is expected to be completed by Q4 2025. To learn more about the Yixing Ophthalmic Drug ADC Production Facility project, buy the profile here.

The project involves the construction of an ophthalmic drug ADC R&D and production facility with a 8,000m2 gross floor area (GFA) in Pharmaceutical Valley B Zone, Yixing, Jiangsu, China.

Smarter leaders trust GlobalData

The project includes the following:

1. Construction of production units
2. Construction of processing units
3. Construction of research facilities
4. Construction of storage units
5. Construction of laboratories
6. Construction of distribution units
7. Construction of an administrative building
8. Construction of parking facilities
9. Installation of machinery and equipment

Construction on the project is expected to be completed by Q4 2025.

For more details on the Yixing Ophthalmic Drug ADC Production Facility project, buy the profile here.

This content was updated on 25 December 2024

Data Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.